PBS listings to save melanoma and multiple sclerosis patients up to $128,900 a year

Australians suffering from melanoma and multiple sclerosis will soon have new treatment options, with new and amended PBS listings on the Pharmaceutical Benefits Scheme (PBS) coming into effect on 1 November.   The Morrison Government will expand the current PBS listings of Tafinlar® (dabrafenib) and Mekinist® (trametinib) to include subsidy for post-surgery treatment for patients…

No room for complacency about polio

On 24 October, we mark World Polio Awareness Day, a reminder that polio is a devastating disease which could easily return if we are not vigilant.   Every Australian needs to understand how important it is to prevent a re-emergence of this debilitating disease.   Thanks to decades of diligent vaccination programs against polio, there…

5AA interview with Leon Byner

E&OE…                       Topics: PBS medicines listings; Correcting inaccurate PBS news story; Drugs shortages   LEON BYNER: Minister, thanks for joining us. You would be aware that News Limited did some work and they are alleging that there are lots of drugs that have been approved for use but are not on the PBS.   They…